RI
RTW Investments Portfolio holdings
AUM
$10B
1-Year Est. Return
135.35%
This Fund
S&P 500
1 Year Est. Return
+135.35%
AUM
$10B
AUM Growth
+$66.4M
(+0.67%)
Holding
98
Top Buys
| 1 | +$282M | |
| 2 | +$271M | |
| 3 | +$189M | |
| 4 |
Tango Therapeutics
TNGX
|
+$164M |
| 5 |
iRhythm Holdings
IRTC
|
+$70.2M |
Top Sells
| 1 | +$269M | |
| 2 | +$162M | |
| 3 | +$92.3M | |
| 4 |
Masimo
MASI
|
+$88.9M |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$85.8M |
Sector Composition
| 1 | Healthcare | 99.92% |
| 2 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Immatics
IMTX
$1.57B
| $127M | 1.26% |
12,869,340
+1,435,986
|
|
||
27
Zai Lab
ZLAB
$1.99B
| $124M | 1.23% |
6,574,032
-385,000
|
|
||
|
BLTE
28
Belite Bio
BLTE
$5.78B
| $114M | 1.13% |
715,332
|
|
||
29
Intuitive Surgical
ISRG
$150B
| $101M | 1.01% |
220,000
+118,772
|
|
||
|
ORKA
30
Oruka Therapeutics
ORKA
$3.53B
| $101M | 1% |
2,058,148
|
|
||
31
GH Research
GHRS
$1.65B
| $83.4M | 0.83% |
5,933,815
|
|
||
32
Xencor
XNCR
$881M
| $81.7M | 0.81% |
6,777,461
|
|
||
33
UroGen Pharma
URGN
$1.37B
| $81.7M | 0.81% |
4,543,895
|
|
||
|
CNTA
34
Centessa Pharmaceuticals
CNTA
$6.15B
| $81.6M | 0.81% |
2,054,175
+263,338
|
|
||
35
Immunovant
IMVT
$6.84B
| $78.9M | 0.79% |
3,177,849
-1
|
|
||
36
Ultragenyx Pharmaceutical
RARE
$2.36B
| $76.4M | 0.76% |
3,648,795
+648,656
|
|
||
|
HNGE
37
Hinge Health
HNGE
$4.35B
| $74.4M | 0.74% |
1,930,000
+1,576,500
|
|
||
38
Castle Biosciences
CSTL
$639M
| $67.7M | 0.67% |
2,758,335
+643,098
|
|
||
39
Rocket Pharmaceuticals
RCKT
$335M
| $63.3M | 0.63% |
17,687,772
|
|
||
40
Taysha Gene Therapies
TSHA
$1.69B
| $61.2M | 0.61% |
13,680,248
-2,718,049
|
|
||
41
Alkermes
ALKS
$7.03B
| $59.1M | 0.59% |
1,672,356
|
|
||
|
CMPS
42
Compass Pathways
CMPS
$1.76B
| $58.8M | 0.59% |
10,632,390
+1,875,000
|
|
||
43
Kodiak Sciences
KOD
$2.3B
| $56.7M | 0.56% |
1,487,934
+1
|
|
||
44
Replimune Group
REPL
$718M
| $56.3M | 0.56% |
7,356,916
+216,564
|
|
||
45
Crinetics Pharmaceuticals
CRNX
$3.75B
| $52.7M | 0.52% |
1,451,326
+100,000
|
|
||
46
uniQure
QURE
$1.8B
| $42.3M | 0.42% |
2,586,356
-1,125,106
|
|
||
|
WAY
47
Waystar Holding Corp
WAY
$3.82B
| $39.3M | 0.39% |
+1,630,000
|
|
||
48
Arrowhead Research
ARWR
$11B
| $36.7M | 0.37% |
585,682
+966
|
|
||
49
Orchestra BioMed
OBIO
$234M
| $35.3M | 0.35% |
8,306,063
|
|
||
50
Verastem
VSTM
$380M
| $34.9M | 0.35% |
6,576,306
|
|